Security Snapshot

DENTSPLY SIRONA Inc. - Equity (XRAY) Institutional Ownership

CUSIP: 24906P109

13F Institutional Holders and Ownership History from Q4 2015 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

355

Shares (Excl. Options)

200,388,379

Price

$11.43

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Equity
Symbol
XRAY on Nasdaq
Shares outstanding
198,498,682
Price per share
$11.60
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
200,388,379
Total reported value
$2,292,369,172
% of total 13F portfolios
0.01%
Share change
-3,803,537
Value change
-$50,461,200
Number of holders
355
Price from insider filings
$11.60
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • XRAY - DENTSPLY SIRONA Inc. - Equity is tracked under CUSIP 24906P109.
  • 355 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 355 to 49 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,292,369,172 to $11,568,094.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 355 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 24906P109?
CUSIP 24906P109 identifies XRAY - DENTSPLY SIRONA Inc. - Equity in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of DENTSPLY SIRONA Inc. - Equity (XRAY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NUANCE INVESTMENTS, LLC 4.5% -33% $123,576,186 -$62,681,052 8,987,359 -34% Nuance Investments LLC 31 Mar 2025
LAZARD ASSET MANAGEMENT LLC 4.4% -14% $108,038,863 -$16,992,855 8,733,942 -14% Lazard Asset Management LLC 31 Dec 2025
AQR CAPITAL MANAGEMENT LLC 2.4% -60% $60,589,942 -$104,138,515 4,898,136 -63% AQR Capital Management, LLC 31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/ 0.1% -103% $2,504,651 -$156,745,230 197,372 -98% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 31 Dec 2025, 355 institutional investors reported holding 200,388,379 shares of DENTSPLY SIRONA Inc. - Equity (XRAY). This represents 101% of the company’s total 198,498,682 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of DENTSPLY SIRONA Inc. - Equity (XRAY) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 11% 21,860,777 -0.66% 0% $249,868,682
BlackRock, Inc. 9.4% 18,704,557 -5.6% 0% $213,793,083
First Eagle Investment Management, LLC 7.4% 14,640,555 +3.2% 0.29% $167,341,544
FULLER & THALER ASSET MANAGEMENT, INC. 6.3% 12,505,510 -2.1% 0.48% $142,937,976
LAZARD ASSET MANAGEMENT LLC 4.4% 8,733,942 -14% 0.17% $99,828,957
COOKE & BIELER LP 4.3% 8,463,488 -0.7% 1% $96,737,668
ARMISTICE CAPITAL, LLC 3.7% 7,298,000 +27% 2% $83,416,140
STATE STREET CORP 3.6% 7,085,434 +2% 0% $82,109,373
ARIEL INVESTMENTS, LLC 2.7% 5,274,740 0.65% $60,290,278
Invenomic Capital Management LP 2.6% 5,132,036 +18% 2.8% $58,659,171
AQR CAPITAL MANAGEMENT LLC 2.5% 4,898,136 -61% 0.03% $55,985,692
D. E. Shaw & Co., Inc. 2.2% 4,434,744 +53% 0.04% $50,689,124
MORGAN STANLEY 1.9% 3,794,956 +32% 0% $43,376,362
GEODE CAPITAL MANAGEMENT, LLC 1.9% 3,735,921 -1.3% 0% $42,710,664
EDMOND DE ROTHSCHILD HOLDING S.A. 1.8% 3,617,300 +5.2% 0.59% $41,345,739
JACOBS LEVY EQUITY MANAGEMENT, INC 1.6% 3,121,993 -32% 0.14% $35,684,380
Brickwood Asset Management LLP 1.5% 2,993,073 +96% 24% $34,210,824
DIMENSIONAL FUND ADVISORS LP 1.4% 2,709,127 -48% 0.01% $30,964,701
PARADIGM CAPITAL MANAGEMENT INC/NY 1.2% 2,398,500 +155% 1.2% $27,414,855
MARSHALL WACE, LLP 1.1% 2,236,786 +1033% 0.02% $25,566,466
BANK OF AMERICA CORP /DE/ 1% 2,056,463 +6.8% 0% $23,505,372
Allianz Asset Management GmbH 0.99% 1,960,746 +45% 0.03% $22,411,327
VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.94% 1,873,777 +34% 0.08% $21,417,271
AMERICAN CENTURY COMPANIES INC 0.9% 1,780,184 +18% 0.01% $20,347,514
CITADEL ADVISORS LLC 0.87% 1,729,647 +61% 0.01% $19,769,865

Institutional Holders of DENTSPLY SIRONA Inc. - Equity (XRAY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 982,354 $11,568,094 +$3,720,536 $11.60 49
2025 Q4 200,388,379 $2,292,369,172 -$50,461,200 $11.43 355
2025 Q3 203,896,581 $2,589,373,475 +$39,408,422 $12.69 405
2025 Q2 199,412,585 $3,167,979,072 +$35,607,998 $15.88 388
2025 Q1 197,913,785 $2,956,010,297 -$87,764,569 $14.94 354
2024 Q4 200,487,575 $3,805,749,415 -$255,501,770 $18.98 354
2024 Q3 208,758,281 $5,642,353,424 -$73,985,278 $27.06 376
2024 Q2 211,758,003 $5,277,004,019 -$10,483,877 $24.91 370
2024 Q1 208,622,753 $6,924,787,936 -$144,758,604 $33.19 442
2023 Q4 212,339,419 $7,558,329,917 +$266,786,057 $35.59 410
2023 Q3 205,240,792 $7,010,141,494 -$35,801,999 $34.16 469
2023 Q2 206,083,224 $8,243,216,694 -$364,374,363 $40.02 464
2023 Q1 215,330,323 $8,457,458,167 -$192,499,891 $39.28 449
2022 Q4 220,962,510 $7,039,839,200 +$209,019,439 $31.84 428
2022 Q3 214,875,796 $6,095,845,188 +$56,809,959 $28.35 431
2022 Q2 207,824,776 $7,427,786,684 -$356,546,199 $35.73 450
2022 Q1 210,388,420 $10,346,474,106 +$106,838,491 $49.22 511
2021 Q4 207,682,205 $11,582,973,304 +$37,585,855 $55.79 522
2021 Q3 207,412,506 $12,037,422,103 +$20,483,073 $58.05 538
2021 Q2 207,010,240 $13,089,456,799 -$113,911,411 $63.26 559
2021 Q1 208,929,128 $13,325,234,518 -$238,549,621 $63.81 526
2020 Q4 213,244,046 $11,165,462,789 -$104,721,988 $52.36 513
2020 Q3 215,553,940 $9,423,123,616 +$52,028,165 $43.73 470
2020 Q2 214,133,294 $9,428,029,420 +$273,689,662 $44.06 489
2020 Q1 208,475,970 $8,091,876,271 -$232,977,034 $38.83 491
2019 Q4 209,598,010 $11,859,780,569 -$110,759,043 $56.59 543
2019 Q3 211,064,829 $11,250,915,506 -$198,132,266 $53.31 516
2019 Q2 214,446,018 $12,513,492,134 -$47,974,539 $58.36 541
2019 Q1 216,661,614 $10,744,629,239 -$257,008,722 $49.59 514
2018 Q4 221,687,598 $8,249,076,816 +$268,623,405 $37.21 475
2018 Q3 214,996,584 $8,113,412,454 -$160,646,172 $37.74 508
2018 Q2 217,134,499 $9,503,421,745 +$97,277,001 $43.77 522
2018 Q1 213,684,457 $10,749,474,094 -$678,395,677 $50.31 546
2017 Q4 222,043,408 $14,614,111,228 +$46,891,150 $65.83 554
2017 Q3 221,611,361 $13,251,327,673 +$369,315,715 $59.81 523
2017 Q2 216,187,178 $14,015,961,189 -$22,361,708 $64.84 532
2017 Q1 216,920,299 $13,545,093,651 +$535,661,196 $62.44 538
2016 Q4 221,863,892 $12,809,550,458 +$105,925,511 $57.73 550
2016 Q3 219,884,153 $13,062,012,628 -$30,275,586 $59.43 526
2016 Q2 220,381,378 $13,672,254,874 -$101,192,501 $62.04 536
2016 Q1 222,444,445 $13,706,877,436 +$13,660,774,207 $61.63 510
2015 Q4 54 $3,000 $55.56 1